Treatment
Atomoxetine clinical trials
We’re tracking 12 recruiting studies that include Atomoxetine, each written for real people, not researchers, below.
Recruiting studies
- NCT06899178RecruitingPhase 2
Atomoxetine for genetic obesity due to MC4R changes
This trial tests a medicine called atomoxetine (Strattera) to help people with a specific genetic form of obesity lose weight. It may be an option if you have a change in the MC4R gene and have not used certain other medications recently.
New York, New YorkAges 6 years+ - NCT05159687RecruitingPhase 3
Atomoxetine to help prevent fainting from vasovagal episodes
This Phase 3 study tests whether atomoxetine can reduce how often vasovagal fainting happens. It may help people who have frequent fainting episodes with triggers like stress or standing for long periods.
Calgary, AlbertaAges 18 years+ - NCT05350215RecruitingPhase 1/Phase 2
Testing atomoxetine and DAW2022 for obstructive sleep apnea severity
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
Boston, MassachusettsAges 21–70 - NCT06573970RecruitingPhase 4
Atomoxetine for PTSD and executive function in veterans
This trial tests if the medication atomoxetine can improve thinking and memory in veterans with PTSD and attention difficulties. It may help those who have not responded fully to other treatments.
Charleston, South CarolinaAges 18–75 - NCT07724132RecruitingPhase 3
Treatments for sustained response in Alzheimer's disease
This study tests whether a treatment (atomoxetine or metformin) can help people with Alzheimer's disease maintain an improved state for at least 18 months. It may help you or a loved one stabilize symptoms and slow disease progression.
CambridgeAges 55 years+ - NCT03781765RecruitingPhase 4
Testing stimulant vs non-stimulant ADHD treatments in young kids
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
New York, New YorkAges 7–12 - NCT04216186RecruitingPhase 3
Coenzyme Q for children with ADHD
This trial tests whether taking coenzyme Q can improve symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. It may help if your child has ADHD, but it excludes certain other conditions.
TantaAges 2–18 - NCT04782830Recruiting
Wearable sensor study for low blood pressure on standing
This study uses an accelerometer (a wearable motion sensor) to measure symptoms and blood pressure changes when you stand up. It may help doctors better track how neurogenic orthostatic hypotension affects you and how well current treatments are working.
Nashville, TennesseeAges 40–80 - NCT05293600RecruitingPhase 1/Phase 2
Rescue medicine trial for sleep apnea after other treatments fail
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
Boston, MassachusettsAges 21–70 - NCT07239791Recruiting
Does a low-dose medication affect how we learn?
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
ParisAges 18–39 - NCT07316296RecruitingPhase 3
Testing a drug to reduce freezing of gait in Parkinson's
This trial tests whether atomoxetine, a drug that boosts a brain chemical called noradrenaline, can help reduce freezing of gait—a feeling of your feet being stuck to the ground—in people with Parkinson's disease. You would continue your usual Parkinson's medications during the study and undergo walking tests and brain scans to see if the drug helps.
Nijmegen, GelderlandAges 18 years+ - NCT06566820Enrolling by invitationPhase 3
Long-term follow-up for sleep apnea study
This is a follow-up study for people with obstructive sleep apnea who have already completed two prior studies with the same medicine. The goal is to keep tracking your health and the medicine's effects over a longer time.
Birmingham, AlabamaAges 18 years+
What Atomoxetine is being studied for
Conditions with recruiting Atomoxetine studies.
Common questions
- Are there clinical trials studying Atomoxetine?
- Yes. Clin2 currently lists 12 recruiting studies that include Atomoxetine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Atomoxetine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Atomoxetine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Atomoxetine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.